Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs
Fabrizio Schifano
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 5, pp. 274-282
Open Access | Times Cited: 17

Showing 17 citing articles:

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers‐Smith, Daniel R. Harris, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 994-994
Open Access | Times Cited: 34
AI as an Epistemic Technology
Ramón Alvarado
Science and Engineering Ethics (2023) Vol. 29, Iss. 5
Closed Access | Times Cited: 23
May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance
Giovanni A. Fava
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 58
What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs
Stefania Chiappini, Fabrizio Schifano
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 736-736
Open Access | Times Cited: 47
Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
Stefania Chiappini, Fabrizio Schifano, John Corkery, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 6, pp. 681-692
Open Access | Times Cited: 40
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
Stefania Chiappini, Rachel Vickers‐Smith, Amira Guirguis, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 565-565
Open Access | Times Cited: 17
The e-psychonaut drugs’ psychopharmacology
Fabrizio Schifano, Stefania Chiappini, John Corkery, et al.
Current Opinion in Pharmacology (2021) Vol. 57, pp. 165-174
Closed Access | Times Cited: 22
Involvement of GABAA Receptors in the Anxiolytic-Like Effect of Hydroxycitronellal
Jéssica Andrade, Álefe Brito Monteiro, Humberto Hugo Nunes de Andrade, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 16
Is there a risk for Semaglutide Misuse? Focus on the Food and Drug Administration-FDA Adverse Events Reporting System (FAERS) pharmacovigilance dataset
Stefania Chiappini, Rachel Vickers‐Smith, Duccio Papanti, et al.
(2023)
Open Access | Times Cited: 6
The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
Valeria Catalani, Michelle J. Botha, John Corkery, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 720-720
Open Access | Times Cited: 15
“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances
George Savulich, Owen Bowden‐Jones, Robert Stephenson, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 9
Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis
Diane Merino, Alexandre O. Gérard, Alexandre Destère, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2972-2972
Open Access | Times Cited: 6
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction
Stefania Chiappini, Fabrizio Schifano, Giovanni Martinotti
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 6
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration-FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers‐Smith, Daniel R. Harris, et al.
(2023)
Open Access | Times Cited: 1
Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction
Fabrizio Schifano, Giovanni Martinotti, Stefania Chiappini, et al.
Frontiers research topics (2021)
Open Access | Times Cited: 2
ACOMPANHAMENTO TERAPÊUTICO DE PACIENTES ATENDIDOS EM UMA UNIDADE BÁSICA DE SAÚDE – FERRAMENTAS DE CUIDADO EM SAÚDE
Beatriz Costa Teixeira, Milena Nunes Alves de Sousa
Temas em Saúde (2023) Vol. 23, Iss. 6, pp. 1-10
Open Access
Recreational Drugs and Men’s Health
Thilakavathi Chengodu, Nathan Lawrentschuk
Springer eBooks (2022), pp. 193-203
Closed Access
Page 1

Scroll to top